Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the nose (HP:0000366)help
Parent Node:
expand
Abnormal nasal mucosa morphology (HP:0000433)help
..Starting node
..expand
Nasal polyposis (HP:0100582)help
Term ID: 100582
Name: Nasal polyposis
Synonym: Nasal polyps; Polyposis nasi; Polyps of nose
Definition: Polypoidal masses arising mainly from the mucous membranes of the nose and paranasal sinuses. They are freely movable and nontender overgrowths of the mucosa that frequently accompany allergic rhinitis.
Comments:
Reference: HP:0100582
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandNasal mucosa telangiectasia (HP:0000434) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0100582HP:0100582Nasal polyposis0CCDC103 CL E G H38838932700ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent36
HP:0100582HP:0100582Nasal polyposis0CCDC39 CL E G H33982925244ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent126
HP:0100582HP:0100582Nasal polyposis0CCDC40 CL E G H5503626090OMIM:613808CILIARY DYSKINESIA, PRIMARY, 15; CILD15182
HP:0100582HP:0100582Nasal polyposis0CCDC40 CL E G H5503626090ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent182
HP:0100582HP:0100582Nasal polyposis0CCDC65 CL E G H8547829937ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent23
HP:0100582HP:0100582Nasal polyposis0CCNO CL E G H1030918576ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent23
HP:0100582HP:0100582Nasal polyposis0CEACAM3 CL E G H10841815ORPHA:586Cystic fibrosis
HP:0100582HP:0100582Nasal polyposis0CEACAM6 CL E G H46801818ORPHA:586Cystic fibrosis1
HP:0100582HP:0100582Nasal polyposis0CFAP221 CL E G H20037333720ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0CFAP298 CL E G H566831301ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0CFAP300 CL E G H8501628188ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0CFTR CL E G H10801884OMIM:219700Cystic fibrosis1371
HP:0100582HP:0100582Nasal polyposis0CFTR CL E G H10801884ORPHA:586Cystic fibrosis1371
HP:0100582HP:0100582Nasal polyposis0CLCA4 CL E G H228022018ORPHA:586Cystic fibrosis
HP:0100582HP:0100582Nasal polyposis0DCTN4 CL E G H5116415518ORPHA:586Cystic fibrosis
HP:0100582HP:0100582Nasal polyposis0DNAAF1 CL E G H12387230539ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent116
HP:0100582HP:0100582Nasal polyposis0DNAAF11 CL E G H2363916725OMIM:614935Ciliary dyskinesia, primary, 19.
HP:0100582HP:0100582Nasal polyposis0DNAAF11 CL E G H2363916725ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0DNAAF2 CL E G H5517220188ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent78
HP:0100582HP:0100582Nasal polyposis0DNAAF3 CL E G H35290930492OMIM:606763Ciliary dyskinesia, primary, 2.63
HP:0100582HP:0100582Nasal polyposis0DNAAF3 CL E G H35290930492ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent63
HP:0100582HP:0100582Nasal polyposis0DNAAF4 CL E G H16158221493ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent27
HP:0100582HP:0100582Nasal polyposis0DNAAF5 CL E G H5491926013ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent62
HP:0100582HP:0100582Nasal polyposis0DNAAF6 CL E G H13921228570ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0DNAH1 CL E G H259812940ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent21
HP:0100582HP:0100582Nasal polyposis0DNAH11 CL E G H87012942ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent542
HP:0100582HP:0100582Nasal polyposis0DNAH5 CL E G H17672950ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent527
HP:0100582HP:0100582Nasal polyposis0DNAH9 CL E G H17702953ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent18
HP:0100582HP:0100582Nasal polyposis0DNAI1 CL E G H270192954OMIM:244400Ciliary dyskinesia, primary, 1.73
HP:0100582HP:0100582Nasal polyposis0DNAI1 CL E G H270192954ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent73
HP:0100582HP:0100582Nasal polyposis0DNAI2 CL E G H6444618744ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent104
HP:0100582HP:0100582Nasal polyposis0DNAJB13 CL E G H37440730718ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent2
HP:0100582HP:0100582Nasal polyposis0DNAL1 CL E G H8354423247ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent167
HP:0100582HP:0100582Nasal polyposis0DRC1 CL E G H9274924245ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent44
HP:0100582HP:0100582Nasal polyposis0ECM1 CL E G H18933153ORPHA:530Lipoid proteinosisHP:0040283 - Occasional14
HP:0100582HP:0100582Nasal polyposis0EDNRA CL E G H19093179ORPHA:586Cystic fibrosis3
HP:0100582HP:0100582Nasal polyposis0FCGR2A CL E G H22123616OMIM:219700Cystic fibrosis6
HP:0100582HP:0100582Nasal polyposis0FOXJ1 CL E G H23023816ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0GAS2L2 CL E G H24617624846ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent1
HP:0100582HP:0100582Nasal polyposis0GAS8 CL E G H26224166ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent9
HP:0100582HP:0100582Nasal polyposis0GCLC CL E G H27294311ORPHA:586Cystic fibrosis2
HP:0100582HP:0100582Nasal polyposis0GSTM3 CL E G H29474635ORPHA:586Cystic fibrosis1
HP:0100582HP:0100582Nasal polyposis0HFE CL E G H30774886ORPHA:586Cystic fibrosis38
HP:0100582HP:0100582Nasal polyposis0HMOX1 CL E G H31625013ORPHA:586Cystic fibrosis3
HP:0100582HP:0100582Nasal polyposis0HYDIN CL E G H5476819368OMIM:608647Ciliary dyskinesia, primary, 5.21
HP:0100582HP:0100582Nasal polyposis0HYDIN CL E G H5476819368ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent21
HP:0100582HP:0100582Nasal polyposis0KCNN4 CL E G H37836293ORPHA:586Cystic fibrosis3
HP:0100582HP:0100582Nasal polyposis0LRRC56 CL E G H11539925430ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0MCIDAS CL E G H34564340050OMIM:618695CILIARY DYSKINESIA, PRIMARY, 42; CILD4213
HP:0100582HP:0100582Nasal polyposis0MCIDAS CL E G H34564340050ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent13
HP:0100582HP:0100582Nasal polyposis0MIF CL E G H42827097ORPHA:586Cystic fibrosis1
HP:0100582HP:0100582Nasal polyposis0NEK10 CL E G H15211018592ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0NME8 CL E G H5131416473ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent50
HP:0100582HP:0100582Nasal polyposis0ODAD1 CL E G H9323326560ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0ODAD2 CL E G H5513025583ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0ODAD3 CL E G H11594828303OMIM:616037Ciliary dyskinesia, primary, 30.
HP:0100582HP:0100582Nasal polyposis0ODAD3 CL E G H11594828303ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0ODAD4 CL E G H8353825280OMIM:617092Ciliary dyskinesia, primary, 35.
HP:0100582HP:0100582Nasal polyposis0ODAD4 CL E G H8353825280ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0OFD1 CL E G H84812567ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent201
HP:0100582HP:0100582Nasal polyposis0PTGER2 CL E G H57329594OMIM:208550Asthma, nasal polyps, and aspirin intolerance.1
HP:0100582HP:0100582Nasal polyposis0RPGR CL E G H610310295ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent200
HP:0100582HP:0100582Nasal polyposis0RSPH1 CL E G H8976512371ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent31
HP:0100582HP:0100582Nasal polyposis0RSPH3 CL E G H8386121054ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent5
HP:0100582HP:0100582Nasal polyposis0RSPH4A CL E G H34589521558ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent58
HP:0100582HP:0100582Nasal polyposis0RSPH9 CL E G H22142121057ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent20
HP:0100582HP:0100582Nasal polyposis0SERPINA1 CL E G H52658941ORPHA:586Cystic fibrosis131
HP:0100582HP:0100582Nasal polyposis0SLC11A1 CL E G H655610907ORPHA:586Cystic fibrosis2
HP:0100582HP:0100582Nasal polyposis0SLC26A9 CL E G H11501914469ORPHA:586Cystic fibrosis5
HP:0100582HP:0100582Nasal polyposis0SLC6A14 CL E G H1125411047ORPHA:586Cystic fibrosis
HP:0100582HP:0100582Nasal polyposis0SLC9A3 CL E G H655011073ORPHA:586Cystic fibrosis7
HP:0100582HP:0100582Nasal polyposis0SPAG1 CL E G H667411212ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent45
HP:0100582HP:0100582Nasal polyposis0SPEF2 CL E G H7992526293ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent15
HP:0100582HP:0100582Nasal polyposis0STK11 CL E G H679411389OMIM:175200Peutz-Jeghers syndrome.740
HP:0100582HP:0100582Nasal polyposis0STK11 CL E G H679411389ORPHA:2869Peutz-Jeghers syndromeHP:0040283 - Occasional740
HP:0100582HP:0100582Nasal polyposis0STK36 CL E G H2714817209ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent3
HP:0100582HP:0100582Nasal polyposis0STX1A CL E G H680411433ORPHA:586Cystic fibrosis
HP:0100582HP:0100582Nasal polyposis0TAP1 CL E G H689043OMIM:604571Bare lymphocyte syndrome, type I.5
HP:0100582HP:0100582Nasal polyposis0TAP2 CL E G H689144OMIM:604571Bare lymphocyte syndrome, type I.17
HP:0100582HP:0100582Nasal polyposis0TAPBP CL E G H689211566OMIM:604571Bare lymphocyte syndrome, type I.3
HP:0100582HP:0100582Nasal polyposis0TBX21 CL E G H3000911599OMIM:208550Asthma, nasal polyps, and aspirin intolerance.1
HP:0100582HP:0100582Nasal polyposis0TGFB1 CL E G H704011766ORPHA:586Cystic fibrosis13
HP:0100582HP:0100582Nasal polyposis0TGFB1 CL E G H704011766OMIM:219700Cystic fibrosis13
HP:0100582HP:0100582Nasal polyposis0TTC12 CL E G H5497023700ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent
HP:0100582HP:0100582Nasal polyposis0UNC119 CL E G H909412565OMIM:615518IMMUNODEFICIENCY 13; IMD1330
HP:0100582HP:0100582Nasal polyposis0ZMYND10 CL E G H5136419412OMIM:615444Ciliary dyskinesia, primary, 22.20
HP:0100582HP:0100582Nasal polyposis0ZMYND10 CL E G H5136419412ORPHA:244Primary ciliary dyskinesiaHP:0040282 - Frequent20


Genes (75) :CCDC103 CCDC39 CCDC40 CCDC65 CCNO CEACAM3 CEACAM6 CFAP221 CFAP298 CFAP300 CFTR CLCA4 DCTN4 DNAAF1 DNAAF11 DNAAF2 DNAAF3 DNAAF4 DNAAF5 DNAAF6 DNAH1 DNAH11 DNAH5 DNAH9 DNAI1 DNAI2 DNAJB13 DNAL1 DRC1 ECM1 EDNRA FCGR2A FOXJ1 GAS2L2 GAS8 GCLC GSTM3 HFE HMOX1 HYDIN KCNN4 LRRC56 MCIDAS MIF NEK10 NME8 ODAD1 ODAD2 ODAD3 ODAD4 OFD1 PTGER2 RPGR RSPH1 RSPH3 RSPH4A RSPH9 SERPINA1 SLC11A1 SLC26A9 SLC6A14 SLC9A3 SPAG1 SPEF2 STK11 STK36 STX1A TAP1 TAP2 TAPBP TBX21 TGFB1 TTC12 UNC119 ZMYND10

Diseases (18) :ORPHA:244 OMIM:613808 ORPHA:586 OMIM:219700 OMIM:614935 OMIM:606763 OMIM:244400 ORPHA:530 OMIM:608647 OMIM:618695 OMIM:616037 OMIM:617092 OMIM:208550 OMIM:175200 ORPHA:2869 OMIM:604571 OMIM:615518 OMIM:615444
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.